Kilpest India Ltd

Kilpest India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kilpest India Ltd

₹ 401 0.05%
29 Mar - close price
kilpest.com BSE: 532067
About

Kilpest is into Crop protection, Public health products and bio-products and is also a supplier to various Govt. organizations, such as FCI (Food Corporation of India), NTPC (National Thermal Power Corporation Limited), Railway, etc. The company is also exporting its products to Bangladesh and Afghanistan.
The company entered into molecular diagnostics with 3B BlackBio BiotechIndia Ltd. [1][2]

Key Points

3B BlackBio Biotech India Limited (Subsidiary) (50% of Consolidated revenue and 90% of profits)
is engaged in the design, development, manufacturing, and commercialization of PCR-based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents. [1]

Website BSE
  • Market Cap ₹ 301 Cr.
  • Current Price ₹ 401
  • High / Low ₹ 500 / 281
  • Stock P/E 13.5
  • Book Value ₹ 214
  • Dividend Yield 0.62 %
  • ROCE 29.9 %
  • ROE 22.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 95.4% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 61.0%

Cons

  • Promoter holding is low: 38.4%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
6.87 6.74 52.89 112.28 42.69 18.88 32.67 15.22 14.36 18.40 11.69 17.31 14.73
4.53 4.36 16.45 32.38 17.72 10.37 14.46 9.22 7.39 12.48 6.51 8.13 7.42
Operating Profit 2.34 2.38 36.44 79.90 24.97 8.51 18.21 6.00 6.97 5.92 5.18 9.18 7.31
OPM % 34.06% 35.31% 68.90% 71.16% 58.49% 45.07% 55.74% 39.42% 48.54% 32.17% 44.31% 53.03% 49.63%
0.05 0.98 0.04 0.08 1.58 1.19 1.55 1.94 1.54 1.87 1.24 1.96 2.88
Interest 0.05 0.15 0.07 0.08 0.03 0.04 0.03 0.06 0.03 -0.02 0.03 0.07 0.05
Depreciation 0.15 0.09 0.15 0.13 0.23 0.11 0.15 0.18 0.17 0.17 0.17 0.24 0.25
Profit before tax 2.19 3.12 36.26 79.77 26.29 9.55 19.58 7.70 8.31 7.64 6.22 10.83 9.89
Tax % 20.55% 26.92% 25.01% 25.12% 25.14% 25.55% 23.70% 23.64% 21.06% 36.91% 24.12% 23.27% 22.04%
Net Profit 1.73 2.28 27.19 59.74 19.67 7.10 14.94 5.88 6.56 4.82 4.72 8.31 7.72
EPS in Rs 2.01 2.68 31.70 69.76 22.98 8.24 17.53 6.85 7.66 5.53 5.39 9.82 8.96
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
21 21 20 22 19 17 16 23 23 29 227 81 62
20 20 19 21 18 16 14 18 16 20 77 44 35
Operating Profit 2 1 1 1 1 2 3 5 7 9 150 37 28
OPM % 8% 5% 6% 6% 7% 9% 16% 23% 31% 32% 66% 46% 44%
0 0 0 0 0 0 0 0 1 2 3 7 8
Interest 0 1 1 1 1 1 1 1 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 1 1 1 1 1
Profit before tax 1 0 1 0 0 0 1 5 7 10 152 43 35
Tax % 33% 104% 34% 14% 23% 23% 19% 24% 25% 23% 25% 26%
Net Profit 1 -0 0 0 0 0 1 3 5 8 114 32 26
EPS in Rs -0.02 0.62 0.59 0.36 0.51 1.76 5.35 8.18 10.24 151.66 42.89 29.70
Dividend Payout % 81% 0% 0% 0% 0% 0% 17% 9% 6% 7% 6% 24%
Compounded Sales Growth
10 Years: 14%
5 Years: 38%
3 Years: 51%
TTM: -23%
Compounded Profit Growth
10 Years: 124%
5 Years: 95%
3 Years: 83%
TTM: -26%
Stock Price CAGR
10 Years: 48%
5 Years: 25%
3 Years: 82%
1 Year: 12%
Return on Equity
10 Years: 49%
5 Years: 57%
3 Years: 61%
Last Year: 23%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
6 6 6 6 6 6 6 6 6 7 7 7 7
Reserves 2 3 3 4 4 4 5 12 16 25 125 146 153
3 6 6 7 8 8 9 6 6 4 2 3 2
7 7 7 7 7 6 6 6 8 9 59 37 44
Total Liabilities 19 22 23 24 25 24 26 30 36 45 194 192 207
4 4 4 4 4 3 3 4 4 4 5 7 7
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 1 59 93 93
15 18 19 20 21 21 22 26 32 40 130 93 107
Total Assets 19 22 23 24 25 24 26 30 36 45 194 192 207

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
-0 0 -1 0 0 1 1 2 4 7 98 37
-1 -1 0 -0 -0 -0 -0 -1 -1 -1 -70 -28
1 1 -0 0 -0 -1 -0 0 -1 1 -2 -15
Net Cash Flow -0 1 -1 0 -0 0 0 1 2 7 26 -6

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 172 180 220 213 262 283 321 259 290 252 56 136
Inventory Days 108 109 149 120 145 143 175
Days Payable 155 165 220 189 218 203 186
Cash Conversion Cycle 125 124 149 144 188 223 310 259 290 252 56 136
Working Capital Days 142 167 214 218 274 312 377 308 351 302 67 169
ROCE % 7% 8% 7% 7% 7% 13% 24% 28% 32% 179% 30%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
38.19 38.19 38.35 38.35 38.35 38.35 38.35 38.43 38.43 38.43 38.43 38.43
0.00 0.00 2.93 1.12 1.10 1.47 0.54 1.23 1.64 1.64 1.64 2.11
0.00 0.00 0.00 0.00 0.00 0.09 0.08 0.08 0.08 0.08 0.00 0.00
61.81 61.81 58.72 60.53 60.55 60.09 61.03 60.26 59.85 59.85 59.94 59.47

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Feb 2023
    Transcript
    Notes
    PPT
  • Sep 2022
    Transcript
    Notes
    PPT
  • Aug 2022
    Transcript
    Notes
    PPT
  • May 2022
    Transcript
    Notes
    PPT
  • Feb 2022
    Transcript
    Notes
    PPT
  • Nov 2021
    Transcript
    Notes
    PPT
  • Sep 2021
    Transcript
    Notes
    PPT
  • Jul 2021
    Transcript
    Notes
    PPT
  • Jun 2021
    Transcript
    Notes
    PPT
  • Feb 2021
    Transcript
    Notes
    PPT
  • Feb 2021
    Transcript
    Notes
    PPT
  • Nov 2020
    Transcript
    Notes
    PPT
  • Sep 2020
    Transcript
    Notes
    PPT
  • Jul 2020
    Transcript
    Notes
    PPT
  • Jun 2020
    Transcript
    Notes
    PPT
  • Feb 2020
    Transcript
    Notes
    PPT
  • Nov 2019
    Transcript
    Notes
    PPT
  • Jul 2019
    Transcript
    Notes
    PPT
  • May 2019
    Transcript
    Notes
    PPT
  • Jan 2019
    Transcript
    Notes
    PPT
  • Nov 2018
    Transcript
    Notes
    PPT
  • Aug 2018
    Transcript
    Notes
    PPT
  • May 2018
    Transcript
    Notes
    PPT
  • Feb 2018
    Transcript
    Notes
    PPT
  • Nov 2017
    Transcript
    Notes
    PPT
  • Jul 2017
    Transcript
    Notes
    PPT
  • Feb 2017
    Transcript
    Notes
    PPT